Innate Pharma Notes AstraZeneca’s Updated Timing For PACIFIC-9 Phase 3 NSCLC Trial Readout: First Half 2027, Not Second Half 2026; Enrollment Complete

Loading news article.

Innate Pharma Notes AstraZeneca’s Updated Timing For PACIFIC-9 Phase 3 NSCLC Trial Readout: First Half 2027, Not Second Half 2026; Enrollment Complete | WAPE

Innate Pharma Notes AstraZeneca’s Updated Timing For PACIFIC-9 Phase 3 NSCLC Trial Readout: First Half 2027, Not Second Half 2026; Enrollment Complete

Article summary

Related companies

Analyzed by WAPE AI.

Comments —